Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-04-000130
Filing Date
2004-02-12
Accepted
2004-02-12 16:07:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. athero.htm SC 13G/A 34561
  Complete submission text file 0000019617-04-000130.txt   36761
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 39TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6021 National Commercial Banks

Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Subject) CIK: 0001107601 (see all company filings)

EIN.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60563 | Film No.: 04591758
SIC: 2834 Pharmaceutical Preparations